**Core Concept**
The uveoscleral outflow pathway is an important route for the drainage of aqueous humor from the eye, playing a significant role in maintaining normal intraocular pressure. Pharmacological manipulation of this pathway can have significant effects on patients with glaucoma.

**Why the Correct Answer is Right**
The correct answer involves a drug that increases uveoscleral outflow by enhancing the permeability of the ciliary body or the suprachoroidal space. This action is typically associated with prostaglandin analogs, which mimic the action of naturally occurring prostaglandins in the eye. These drugs promote the opening of the uveoscleral pathway, allowing for increased aqueous humor outflow and consequently reducing intraocular pressure.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option would be incorrect because it is not directly related to the uveoscleral outflow pathway. Drugs that primarily act on the trabecular meshwork, such as beta-blockers, would be more likely to increase outflow through the conventional pathway.
* **Option B:** This option is incorrect because while it may have some effect on intraocular pressure, it is not directly related to the uveoscleral outflow pathway. Drugs that reduce intraocular pressure through other mechanisms, such as carbonic anhydrase inhibitors, would not primarily act by increasing uveoscleral outflow.
* **Option C:** This option is incorrect because it would not increase uveoscleral outflow. Drugs that reduce intraocular pressure through other mechanisms, such as parasympathomimetics, would not primarily act by increasing uveoscleral outflow.

**Clinical Pearl / High-Yield Fact**
Prostaglandin analogs are a class of medications that are highly effective in reducing intraocular pressure by increasing uveoscleral outflow. These medications are often used as first-line treatment for patients with glaucoma, particularly those with open-angle glaucoma.

**Correct Answer: C. Latanoprost**